TITLE

Gut: Why do the different people's bodies react differently to a high-fat diet?

PUB. DATE
April 2012
SOURCE
Biomedical Market Newsletter;4/28/2012, Vol. 21, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on a study, according to which the composition of the gut flora determine the way in which the body develops metabolic disorders such as diabetes, regardless of any genetic modification, gender, age or specific diet.
ACCESSION #
76119526

 

Related Articles

  • The hybrid science of diet, microbes, and metabolic health. Shanahan, Fergus; Murphy, Eileen // American Journal of Clinical Nutrition;Jul2011, Vol. 94 Issue 1, p1 

    The author discusses the interactions of diet, microbes, and fat metabolism as well as the risk of metabolic disease. The author cites evidence linking the effect of disturbances of innate immunity on microbiota which adversely influence inflammatory response and risk of obesity and diabetes....

  • High-Fat Diet Alters the Intestinal Microbiota in Streptozotocin-Induced Type 2 Diabetic Mice. Liu, Sheng; Qin, Panpan; Wang, Jing // Microorganisms;Jun2019, Vol. 7 Issue 6, p176 

    Intestinal microbiota is closely associated with various metabolic diseases such as type 2 diabetes (T2D), and microbiota is definitely affected by diet. However, more work is required to gain detailed information about gut metagenome and their associated impact with diet in T2D patients. We...

  • Gut Microbiota and Host Metabolism: What Relationship. Mithieux, Gilles // Neuroendocrinology;May2018, Vol. 106 Issue 4, p352 

    A large number of genomic studies have reported associations between the gut microbiota composition and metabolic diseases such as obesity or type 2 diabetes. This led to the widespread idea that a causal relationship could exist between intestinal microbiota and metabolic diseases. At odds with...

  • Gut Microbiota Signatures Predict Host and Microbiota Responses to Dietary Interventions in Obese Individuals. Korpela, Katri; Flint, Harry J.; Johnstone, Alexandra M.; Lappi, Jenni; Poutanen, Kaisa; Dewulf, Evelyne; Delzenne, Nathalie; de Vos, Willem M.; Salonen, Anne // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Background: Interactions between the diet and intestinal microbiota play a role in health and disease, including obesity and related metabolic complications. There is great interest to use dietary means to manipulate the microbiota to promote health. Currently, the impact of dietary change on...

  • Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice. Bindels, Laure B.; Neyrinck, Audrey M.; Salazar, Nuria; Taminiau, Bernard; Druart, Céline; Muccioli, Giulio G.; François, Emmanuelle; Blecker, Christophe; Richel, Aurore; Daube, Georges; Mahillon, Jacques; de los Reyes-Gavilán, Clara G.; Cani, Patrice D.; Delzenne, Nathalie M. // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    We tested the hypothesis that changing the gut microbiota using pectic oligosaccharides (POS) or inulin (INU) differently modulates the progression of leukemia and related metabolic disorders. Mice were transplanted with Bcr-Abl-transfected proB lymphocytes mimicking leukemia and received either...

  • Gut microbiome and its role in obesity and insulin resistance. Lee, Clare J.; Sears, Cynthia L.; Maruthur, Nisa // Annals of the New York Academy of Sciences;Feb2020, Vol. 1461 Issue 1, p37 

    Obesity is a complex metabolic disease caused, in part, by the interaction between an individual's genetics, metabolism, and environment. Emerging evidence supports the role of gut microbiota in mediating the interaction between the host and environment by extracting energy from food otherwise...

  • Intl Liver Congress 2012: Gut microbiota transplantation may prevent development of diabetes and fatty liver disease.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article offers information on a data presented at the International Liver Congress 2012 which revealed that the gut microbiota transplantation may prevent the development of diabetes and nonalcoholic fatty liver disease.

  • No guts no glory. Bramley, Vicki; Bramley, Lynsey // Australian Women's Weekly;Jul2019, p130 

    The article focuses on gut that could play a part in treatment of chronic conditions like allergies, diabetes, depression and anxiety. It presents a study which reveals that taking probiotic tablets after antibiotics can prevent your natural flora from growing back, probably because the tablet...

  • Astragalus alters gut-microbiota composition in type 2 diabetes mice: clues to its pharmacology. Li, Xin-Yu; Shen, Liang; Ji, Hong-Fang // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;May2019, Vol. 12, p771 

    Background: Astragalus possesses therapeutic effects for type 2 diabetes (T2D), while its action mechanisms remain to be elucidated. In view of the pathogenic associations between gut microbiota and T2D, we explored the effect of astragalus on gut-microbiota composition of T2D mice. Materials...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics